WASSIM SAMRA
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology JACKSONVILLE, FL NPI 1780947754
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology FL Novo Nordisk AS All categories
General Payments — all program years on this page
$841.37
- Category: General Payments
- Program years: PY2018–2020
- Record count: 13
- As of (CMS publication): 2026-01-23
Latest program year (PY2020): $671.41 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2020) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Grant | $408.19 | 1 |
| Education | $190.00 | 2 |
| Food and Beverage | $73.22 | 4 |
By paying entity
Latest program year (PY2020) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $408.19 | 1 |
| Amgen Inc. | $190.00 | 2 |
| Celgene Corporation | $59.64 | 3 |
| SEAGEN INC. | $13.58 | 1 |
By program year
Records — PY2020 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 727876783 | Celgene Corporation | $23.52 | 01/07/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 727876787 | Celgene Corporation | $11.80 | 01/31/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 727876790 | Celgene Corporation | $24.32 | 02/18/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 732457653 | Seagen Inc. | $13.58 | 02/14/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 741462757 | Amgen Inc. | $95.00 | 04/27/2020 | Education | Undisputed | 01/23/2026 | View at CMS |
| 741462759 | Amgen Inc. | $95.00 | 05/21/2020 | Education | Undisputed | 01/23/2026 | View at CMS |
| 744802703 | Novo Nordisk Inc | $408.19 | 01/22/2020 | Grant | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.